Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
73M
-
Shares change
-
+702K
-
Total reported value, excl. options
-
$1.4B
-
Value change
-
-$74.3M
-
Put/Call ratio
-
0.05
-
Number of buys
-
141
-
Number of sells
-
-160
-
Price
-
$19.16
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2025
365 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2025.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73M shares
.
Largest 10 shareholders include BlackRock, Inc. (11M shares), VANGUARD GROUP INC (7.29M shares), Sessa Capital IM, L.P. (4.47M shares), GW&K Investment Management, LLC (2.86M shares), ArrowMark Colorado Holdings LLC (2.72M shares), STATE STREET CORP (2.69M shares), Hood River Capital Management LLC (2.31M shares), Stephens Investment Management Group LLC (1.71M shares), Paradice Investment Management LLC (1.65M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.56M shares).
This table shows the top 271 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.